Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[New strategies for BMT].

Susumu Ikehara1

  • 1First Department of Pathology, Transplantation Center, Regeneration Research Center for Intractable Diseases, Kansai Medical University.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|January 4, 2003
PubMed
Summary

Intra-bone marrow bone marrow transplantation (IBM-BMT) offers a superior method for allogeneic bone marrow transplantation (allo BMT) and organ allografts. This novel technique overcomes challenges like graft-versus-host disease, improving tolerance induction for autoimmune disease treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pilomatrical carcinosarcoma in the very elderly: A case report.

Molecular and clinical oncology·2021
Same author

A case of high-grade mucinous tubular and spindle cell carcinoma.

Journal of surgical case reports·2020
Same author

An Autopsy Case of Rupture of Infectious Thoracic Aortitis Induced by Methicillin-Resistant Staphylococcus Aureus.

The American journal of case reports·2019
Same author

Malignant rhabdoid tumour in an adult kidney: A case report.

Molecular and clinical oncology·2019
Same author

Extra-gastrointestinal stromal tumor with a large cyst.

Journal of surgical case reports·2019
Same author

Large-cell neuroendocrine carcinoma arising in the endometrium: A case report.

Molecular and clinical oncology·2018

Area of Science:

  • Immunology
  • Transplantation immunology
  • Regenerative medicine

Context:

  • Allogeneic bone marrow transplantation (allo BMT) shows promise for treating autoimmune diseases, with recent human confirmations.
  • Conventional allo BMT faces challenges in humans, including graft-versus-host disease (GvHD), graft rejection, and poor T-cell recovery, especially across major histocompatibility complex (MHC) barriers.

Purpose:

  • To introduce and evaluate a novel intra-bone marrow bone marrow transplantation (IBM-BMT) method.
  • To demonstrate the efficacy of IBM-BMT in overcoming limitations of conventional allo BMT and inducing persistent tolerance.

Summary:

  • A new bone marrow transplantation (BMT) technique, intra-bone marrow bone marrow transplantation (IBM-BMT), involves direct injection of bone marrow cells (BMCs) into the bone marrow.
  • This study demonstrates that IBM-BMT is a superior strategy for allo BMT and organ allografts, effectively inducing persistent tolerance.
  • The IBM-BMT method addresses key barriers in human transplantation, including GvHD and graft rejection.

Impact:

  • IBM-BMT represents a significant advancement in transplantation, offering a more effective approach for treating autoimmune diseases.
  • This method holds potential for improving the success rates of allogeneic transplantation and organ allografts, leading to better patient outcomes.
  • The induction of persistent tolerance via IBM-BMT could revolutionize the management of autoimmune conditions and reduce transplant-related complications.

Related Experiment Videos